VivoSeq
Other

Extracorporeal Membrane Oxygenation

0

Pipeline Programs

8

Active Trials

0

Companies Involved

Extracorporeal Membrane Oxygenation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

12/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Recruiting5 · 29%
Completed4 · 24%
Unknown status3 · 18%
Active, not recruiting2 · 12%
Terminated2 · 12%
Not yet recruiting1 · 6%

Trial Activity

17 trials

Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
Active, not recruiting··Phase 4·NCT04496362·100 enrolled
TITRE: Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
Active, not recruiting·BBoston Children's Hospital·Preclinical·NCT05405426·228 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)